Chloroquine Syrup

About Chloroquine 80 mg/5 ml Syrup

Chloroquine Phosphate is an anti-malarial medicine. This brand, Chloroquine, is a syrup (80 mg/5 ml) from Standard Laboratories Ltd., used in malaria and some other conditions as a doctor prescribes.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Chloroquine 80 mg/5 ml Syrup?

Chloroquine Phosphate belongs to the anti-malarial group of drugs. It is active against the malaria parasites that cause illness in the blood and is used for treating malaria and for preventing it in some situations. It is also used in some forms of amoebic liver infection and in certain long-term conditions such as rheumatoid arthritis and lupus, but only when a doctor decides it is suitable. The syrup form makes it easier to give to people who cannot swallow tablets. Doses are always set by the doctor based on the person's age, weight, and condition. Never change the amount or stop the medicine without medical advice.

Uses of Chloroquine

Chloroquine Phosphate is used to treat malaria and to prevent and suppress it in people who are at risk. It is also used in the treatment of amoebic hepatitis and amoebic liver abscess, and in some inflammatory conditions such as discoid and systemic lupus erythematosus and rheumatoid arthritis. Only a qualified doctor can decide whether this medicine is right for a particular person, and the dose and length of treatment are always chosen by the doctor.

How to use Chloroquine

This medicine comes as a syrup (80 mg/5 ml) and is taken by mouth. The exact amount and how often to take it depend on the reason it is being used and on the person's age and weight; your doctor will decide the dose and course. Measure the syrup with a proper measuring spoon or syringe rather than a household spoon. Take it exactly as instructed, and do not stop early or take extra. If you miss a dose, ask your doctor or pharmacist what to do. Keep all appointments for check-ups.

Side effects of Chloroquine

At usual doses, chloroquine is generally well tolerated. Some people may get headache or stomach upset such as nausea or loose stools. These are usually not serious. With long-term use at high doses, side effects can be more serious and may include skin rashes, changes in skin colour, hair loss, difficulty focusing the eyes, or blurred vision. Rarely, blood problems such as low platelets or anaemia have been reported. Long-term high doses can rarely cause serious eye damage. Tell your doctor if you notice any unusual symptoms, especially vision changes.

Safety and precautions

Chloroquine should be used with caution in people with porphyria, especially if they also have liver problems, as it may worsen symptoms. If you take it for a long time, your doctor may arrange regular eye checks. Use during pregnancy should be avoided unless the doctor judges that the benefit outweighs the risk, such as in a threatening infection. Breastfeeding mothers should ask their doctor before using it. Tell your doctor about all other medicines you take, because chloroquine can interact with some drugs, including phenylbutazone, neostigmine, pyridostigmine, ampicillin, and cimetidine. People with liver or kidney problems, or any long-term illness, should check with their doctor first.

Frequently asked questions

Is Chloroquine safe to use during pregnancy or breastfeeding?

Pregnancy: use should be avoided if possible, unless your doctor decides the benefit outweighs the risk, for example in a serious infection. Breastfeeding: ask your doctor before using this medicine, as they will consider your individual situation and whether it is suitable.

What is Chloroquine used for and what kind of medicine is it?

It is an anti-malarial medicine. It is used to treat malaria and to prevent and suppress it, and also for amoebic hepatitis and abscess, discoid and systemic lupus erythematosus, and rheumatoid arthritis. Only a doctor can decide if it is right for you and prescribe the dose.

How should I store the syrup?

Store at room temperature in a dry place, away from light. Keep it out of reach of children. Do not use after the expiry date printed on the pack. If you are unsure about storage, ask your pharmacist.

Can I take other medicines while using Chloroquine?

Some medicines can interact with chloroquine, including phenylbutazone, neostigmine, pyridostigmine, ampicillin, and cimetidine. Always tell your doctor or pharmacist about all medicines you are taking, including ones bought without a prescription, so they can check for interactions.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.